Existing drug has potential for immune paralysis

**Study Shows Existing Drug May Reactivate Dysfunctional Immune Cells in ICU Patients**

Researchers at Radboud University Medical Center have identified an existing drug that can potentially restore the function of immune cells that are not operating correctly. Their study focuses on immune paralysis, a condition where the immune system becomes impaired, leaving individuals more vulnerable to infections from viruses, bacteria, or fungi. The findings could inform future research aimed at improving outcomes for patients in intensive care units (ICUs), particularly those suffering from sepsis.

The study highlights how the drug was able to revive malfunctioning immune cells in laboratory settings. Immune paralysis is a critical issue for ICU patients with sepsis, as their weakened immune systems struggle to fight off infections effectively. While the research does not yet confirm clinical applications, it provides a foundation for further investigation into how this drug might be used to address immune dysfunction in severely ill patients. Researchers emphasize that additional studies will be necessary to explore its potential benefits and safety in real-world medical scenarios.

Newsflash | Powered by GeneOnline AI

Source: https://www.worldpharmanews.com/research/6821-existing-drug-has-potential-for-immune-paralysis

Related posts:

Study Reveals How ‘Two-Hit Stress’ During Pregnancy Impacts Brain and Behavior in Mice Neural Structures in the Medial Prefrontal Cortex Linked to Avoidant Behaviors Protein Suppression as Potential Pathway for Glioblastoma Immunotherapy Police and Hospitals’ Drug Confiscation Practices Examined

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後